NCT06310044

Brief Summary

Clinically compare the post-operative pain , incidences post-operative swelling , post-operative number of analgesic tablets taken by patient and amount of bacterial load reduction after using 50% Commiphora Myrrh Chemomechanical preparation , versus 2.5% NaOCl,in asymptomatic necrotic mandibular premolar treated in single visit.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 7, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 13, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

March 13, 2024

Status Verified

March 1, 2024

Enrollment Period

8 months

First QC Date

March 7, 2024

Last Update Submit

March 7, 2024

Conditions

Keywords

Asymptomatic Necrotic Mandibular Premolar

Outcome Measures

Primary Outcomes (1)

  • Post-operative pain

    Categorical None 0 Mild 1-3 Moderate 4-6 Sever 7-10

    Post-operative pain measured at 6,12,24,48 hours after single visit Treatment

Secondary Outcomes (1)

  • incidence of Post-operative swelling

    Up to 48 hours post-

Other Outcomes (2)

  • Amount of intracanal Bacterial CFUs/ml

    Pre-intervention, pre-instrumentation after access cavity. Post-instrumentation up to 10min

  • Number of analgesic Counting Tablets taken by the patient after endodontic treatment

    Up to 48hours post-operative

Study Arms (2)

Commiphora Myrrh

EXPERIMENTAL

50% Commiphora Myrrh

Other: Root canal irrigant Commiphora Myrrh 50%

Sodium hypochlorite

ACTIVE COMPARATOR

2.5% NaOCl

Other: Root canal irrigant Commiphora Myrrh 50%

Interventions

Root canal irrigant

Commiphora MyrrhSodium hypochlorite

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Systemically healthy patient (ASA I, II).
  • Age between 20 and 40 years.
  • Male or female.
  • Patient who is able to sign and comprehend the pain scale (committed patient).
  • Mandibular single rooted premolars having the following criteria:
  • With single root canal.
  • Diagnosed clinically with pulp necrosis.
  • Absence of spontaneous pulpal pain.
  • Positive pain on percussion denoting apical periodontitis.
  • Slight widening of periodontal space or peri-apical radiolucency smaller than 3 mm (0-2mm)

You may not qualify if:

  • Medically compromised patients (ASA III or IV).
  • Teeth with:
  • Patients who could not interpret the NRS.
  • Immature roots.
  • Vital pulp tissues.
  • Association with swelling.
  • Acute peri-apical abscess or acute exacerbation of a chronic abscess.
  • Mobility Grade II or III.
  • Previously accessed or endodontically treated.
  • Deep periodontal pockets more than 4 mm.
  • Vertical root fractures, coronal perforation, calcification, and external or internal root resorptions.
  • Patients with diabetes, immune-compromising, and immunosuppression disease and pregnant women will be also excluded.
  • History of intolerance to NSAIDs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Dental Pulp Necrosis

Condition Hierarchy (Ancestors)

Dental Pulp DiseasesTooth DiseasesStomatognathic DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

March 7, 2024

First Posted

March 13, 2024

Study Start

May 1, 2024

Primary Completion

January 1, 2025

Study Completion

January 1, 2025

Last Updated

March 13, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will share